Communities›Breast Cancer Clinical Trials›Should I take Kisqali for early-stage breast cancer?

Should I take Kisqali for early-stage breast cancer?

Community Member

7 months ago

My doctor is saying is should take the following regimen of lupron, letrozole, kisqali. I am early stage breast cancer with no chemo or radiation. Had a double mastectomy. I feel the kisqali is excessive and not worth the side effects for 1-2% decrease in recurrence. Per my onco type it’s a 5% chance of recurrence. This treatment was just approved sept 2024 by the fda. I do not want to be a doctors quota for this trial. She kept speaking about all the commercials for kisqali on TV. I’m 40 years old and side effects for kisqali are not great. Anyone with thoughts?

14 comments

Comment

Accepted Answer

This is such a personal and important decision that only you and your medical team can make together. It's completely understandable to have concerns about side effects and want to weigh the benefits carefully, especially with a newly approved treatment. Many people in this community have faced similar decisions about adjuvant therapies and found it helpful to seek a second opinion or ask their oncologist for more detailed information about the specific benefits in their case. Have others here had experience discussing treatment options when the projected benefits feel small compared to potential quality of life impacts?

3+ patients found this helpful

New to the community?

Create an account to connect with others navigating cancer.

Should I take Kisqali for early-stage breast cancer?

Related Questions